Vivax malaria: neglected and not benign

Vivax malaria: neglected and not benign

2007 December ; 77(6 Suppl): 79–87 | Ric N Price, Emiliana Tjitra, Carlos A Guerra, Shunmay Yeung, Nicholas J White, and Nicholas M Anstey
The article "Vivax Malaria: Neglected and Not Benign" by Ric N. Price et al. highlights the significant global burden of *Plasmodium vivax* malaria, which is often underestimated. Despite accounting for 132-391 million clinical infections annually, primarily in South East Asia and the Western Pacific, *P. vivax* is frequently overlooked compared to *P. falciparum*. The authors emphasize that *P. vivax* can cause severe and fatal infections, particularly in young children and pregnant women, and can lead to chronic debilitation and anemia. The parasite's ability to relapse and its preference for invading young red blood cells contribute to its persistence and transmission. The lack of reliable diagnosis and effective treatment options, such as chloroquine resistance, further exacerbate the problem. The article calls for improved access to diagnostic tools and effective treatments, as well as more detailed epidemiological and economic studies to raise awareness and prioritize *P. vivax* in global malaria control efforts.The article "Vivax Malaria: Neglected and Not Benign" by Ric N. Price et al. highlights the significant global burden of *Plasmodium vivax* malaria, which is often underestimated. Despite accounting for 132-391 million clinical infections annually, primarily in South East Asia and the Western Pacific, *P. vivax* is frequently overlooked compared to *P. falciparum*. The authors emphasize that *P. vivax* can cause severe and fatal infections, particularly in young children and pregnant women, and can lead to chronic debilitation and anemia. The parasite's ability to relapse and its preference for invading young red blood cells contribute to its persistence and transmission. The lack of reliable diagnosis and effective treatment options, such as chloroquine resistance, further exacerbate the problem. The article calls for improved access to diagnostic tools and effective treatments, as well as more detailed epidemiological and economic studies to raise awareness and prioritize *P. vivax* in global malaria control efforts.
Reach us at info@study.space
Understanding Vivax malaria%3A neglected and not benign.